{"id":"https://openalex.org/W14506558","doi":"https://doi.org/10.1096/fasebj.26.1_supplement.1038.6","title":"Modulation of mdr\u20101 Expression and Activity by Verapamil and Resveratrol Potentiates the Cytotoxicity of Docetaxel and Doxorubicin in Solid Tumor Cell Lines","display_name":"Modulation of mdr\u20101 Expression and Activity by Verapamil and Resveratrol Potentiates the Cytotoxicity of Docetaxel and Doxorubicin in Solid Tumor Cell Lines","publication_year":2012,"publication_date":"2012-04-01","ids":{"openalex":"https://openalex.org/W14506558","doi":"https://doi.org/10.1096/fasebj.26.1_supplement.1038.6","mag":"14506558"},"language":"en","primary_location":{"id":"doi:10.1096/fasebj.26.1_supplement.1038.6","doi":"https://doi.org/10.1096/fasebj.26.1_supplement.1038.6","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.26.1_supplement.1038.6","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000912075","display_name":"Mohamed Ahmed El\u2010Moselhy","orcid":"https://orcid.org/0000-0003-1141-7832","observed_orcids":["https://orcid.org/0000-0003-1141-7832"]},"institutions":[{"id":"https://openalex.org/I89466785","display_name":"Minia University","ror":"https://ror.org/02hcv4z63","country_code":"EG","type":"education","lineage":["https://openalex.org/I89466785"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Mohamed Ahmed Mohamed El-Moselhy","raw_affiliation_strings":["<!--<label><sup>1</sup></label>--> Pharmacology and Toxicology Faculty of Pharmacy El- Minia University El-Minia Egypt","1--> Pharmacology and Toxicology Faculty of Pharmacy El- Minia University El-Minia Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"<!--<label><sup>1</sup></label>--> Pharmacology and Toxicology Faculty of Pharmacy El- Minia University El-Minia Egypt","institution_ids":["https://openalex.org/I89466785"]},{"raw_affiliation_string":"1--> Pharmacology and Toxicology Faculty of Pharmacy El- Minia University El-Minia Egypt","institution_ids":["https://openalex.org/I89466785"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111904055","display_name":"Gamal A. El-Sherbiny","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I113643904","display_name":"Beni-Suef University","ror":"https://ror.org/05pn4yv70","country_code":"EG","type":"education","lineage":["https://openalex.org/I113643904"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Gamal Ahmed El-Sherbiny","raw_affiliation_strings":["<!--<label><sup>2</sup></label>--> Pharmacology and Toxicology faculty of pharmacy Beni-Suif University Beni-Suif Egypt","2--> Pharmacology and Toxicology faculty of pharmacy Beni-Suif University Beni-Suif Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"<!--<label><sup>2</sup></label>--> Pharmacology and Toxicology faculty of pharmacy Beni-Suif University Beni-Suif Egypt","institution_ids":["https://openalex.org/I113643904"]},{"raw_affiliation_string":"2--> Pharmacology and Toxicology faculty of pharmacy Beni-Suif University Beni-Suif Egypt","institution_ids":["https://openalex.org/I113643904"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110698900","display_name":"H. Abdellatif","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145487455","display_name":"Cairo University","ror":"https://ror.org/03q21mh05","country_code":"EG","type":"education","lineage":["https://openalex.org/I145487455"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Hekma Abdel-Tawab Abd Abdel-Latif","raw_affiliation_strings":["<!--<label><sup>3</sup></label>--> Pharmacology and Toxicology faculty of pharmacy Cairo University cairo Egypt","3--> Pharmacology and Toxicology faculty of pharmacy Cairo University cairo Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"<!--<label><sup>3</sup></label>--> Pharmacology and Toxicology faculty of pharmacy Cairo University cairo Egypt","institution_ids":["https://openalex.org/I145487455"]},{"raw_affiliation_string":"3--> Pharmacology and Toxicology faculty of pharmacy Cairo University cairo Egypt","institution_ids":["https://openalex.org/I145487455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048933882","display_name":"Ahmed Mohamed Al-Abd","orcid":"https://orcid.org/0000-0001-7872-4867","observed_orcids":["https://orcid.org/0000-0001-7872-4867"]},"institutions":[{"id":"https://openalex.org/I4210131959","display_name":"National Research Centre","ror":"https://ror.org/02n85j827","country_code":"EG","type":"facility","lineage":["https://openalex.org/I4210131959"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Ahmed Mohamed Al-Abd","raw_affiliation_strings":["<!--<label><sup>4</sup></label>--> pharmacology National Research Center cairo Egypt","4--> pharmacology National Research Center cairo Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"<!--<label><sup>4</sup></label>--> pharmacology National Research Center cairo Egypt","institution_ids":["https://openalex.org/I4210131959"]},{"raw_affiliation_string":"4--> pharmacology National Research Center cairo Egypt","institution_ids":["https://openalex.org/I4210131959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103335265","display_name":"Salwa Mohamed Nofal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131959","display_name":"National Research Centre","ror":"https://ror.org/02n85j827","country_code":"EG","type":"facility","lineage":["https://openalex.org/I4210131959"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Salwa Mohamed Nofal","raw_affiliation_strings":["<!--<label><sup>4</sup></label>--> pharmacology National Research Center cairo Egypt","4--> pharmacology National Research Center cairo Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"<!--<label><sup>4</sup></label>--> pharmacology National Research Center cairo Egypt","institution_ids":["https://openalex.org/I4210131959"]},{"raw_affiliation_string":"4--> pharmacology National Research Center cairo Egypt","institution_ids":["https://openalex.org/I4210131959"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089577528","display_name":"Wafaa I. El\u2010Eraky","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131959","display_name":"National Research Centre","ror":"https://ror.org/02n85j827","country_code":"EG","type":"facility","lineage":["https://openalex.org/I4210131959"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Wafaa Ibraheem El-Eraky","raw_affiliation_strings":["<!--<label><sup>4</sup></label>--> pharmacology National Research Center cairo Egypt","4--> pharmacology National Research Center cairo Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"<!--<label><sup>4</sup></label>--> pharmacology National Research Center cairo Egypt","institution_ids":["https://openalex.org/I4210131959"]},{"raw_affiliation_string":"4--> pharmacology National Research Center cairo Egypt","institution_ids":["https://openalex.org/I4210131959"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3740,"currency":"USD","value_usd":3740},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.00195406,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":96},"biblio":{"volume":"26","issue":"S1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/p-glycoprotein","display_name":"P-glycoprotein","score":0.8640000224113464},{"id":"https://openalex.org/keywords/mdr-1-gene","display_name":"MDR-1 gene","score":0.8450000286102295},{"id":"https://openalex.org/keywords/verapamil","display_name":"verapamil","score":0.9440000057220459},{"id":"https://openalex.org/keywords/resveratrol","display_name":"resveratrol","score":1.0},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.9430000185966492},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":1.0},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.6370000243186951},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.5770000219345093},{"id":"https://openalex.org/keywords/multidrug-resistance","display_name":"multidrug resistance","score":0.7850000262260437},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.46799999475479126},{"id":"https://openalex.org/keywords/bax","display_name":"Bax","score":0.7480000257492065},{"id":"https://openalex.org/keywords/bcl-2","display_name":"Bcl-2","score":0.9589999914169312},{"id":"https://openalex.org/keywords/p53","display_name":"p53","score":0.9980000257492065},{"id":"https://openalex.org/keywords/solid-tumor-cell-lines","display_name":"solid tumor cell lines","score":0.6769999861717224},{"id":"https://openalex.org/keywords/drug-efflux-inhibition","display_name":"drug efflux inhibition","score":0.7269999980926514}],"concepts":[{"id":"https://openalex.org/C2777022698","wikidata":"https://www.wikidata.org/wiki/Q410291","display_name":"Verapamil","level":3,"score":0.8954818248748779},{"id":"https://openalex.org/C2776816829","wikidata":"https://www.wikidata.org/wiki/Q407329","display_name":"Resveratrol","level":2,"score":0.8888341188430786},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.8214342594146729},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.8002901077270508},{"id":"https://openalex.org/C200082930","wikidata":"https://www.wikidata.org/wiki/Q22327148","display_name":"Efflux","level":2,"score":0.7476590871810913},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.7158480286598206},{"id":"https://openalex.org/C2777366897","wikidata":"https://www.wikidata.org/wiki/Q847482","display_name":"HeLa","level":3,"score":0.6909738779067993},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.6572175025939941},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6147454977035522},{"id":"https://openalex.org/C79879829","wikidata":"https://www.wikidata.org/wiki/Q5571762","display_name":"Intracellular","level":2,"score":0.5973851680755615},{"id":"https://openalex.org/C2778707650","wikidata":"https://www.wikidata.org/wiki/Q412902","display_name":"P-glycoprotein","level":4,"score":0.5923599004745483},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.4407055079936981},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.4157707691192627},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.3427223265171051},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2719684839248657},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2649805247783661},{"id":"https://openalex.org/C133936738","wikidata":"https://www.wikidata.org/wiki/Q643839","display_name":"Multiple drug resistance","level":3,"score":0.2387423813343048},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.21661874651908875},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.19316551089286804},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.18048691749572754},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.16726556420326233},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.15131032466888428},{"id":"https://openalex.org/C519063684","wikidata":"https://www.wikidata.org/wiki/Q706","display_name":"Calcium","level":2,"score":0.050792157649993896},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1096/fasebj.26.1_supplement.1038.6","doi":"https://doi.org/10.1096/fasebj.26.1_supplement.1038.6","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.26.1_supplement.1038.6","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2004357107","https://openalex.org/W2740003291","https://openalex.org/W2113127278","https://openalex.org/W2056137128","https://openalex.org/W2748952677","https://openalex.org/W2122403713","https://openalex.org/W2070243196","https://openalex.org/W2088292832","https://openalex.org/W2008332040","https://openalex.org/W2471357160"],"abstract_inverted_index":{"P\u2010glycoprotein":[0],"(P\u2010gp)":[1],"is":[2],"a":[3],"member":[4],"of":[5,20,32,41,76,92,115,133,140,153,176,199,218],"ATP\u2010dependent":[6],"membrane":[7],"transport":[8],"protein":[9],"superfamily":[10],"encoded":[11],"by":[12,192],"mdr\u20101":[13,177],"gene":[14],"family.":[15],"In":[16,206],"tumor":[17,60],"cells,":[18],"expression":[19,175],"P\u2010gp":[21,44,186,200],"results":[22],"in":[23,58,160,213,222],"reduced":[24],"intracellular":[25,204],"drug":[26],"concentrations,":[27],"which":[28],"decreases":[29],"the":[30,38,54,111,131,174,203,215],"cytotoxicity":[31],"antitumor":[33],"drugs.":[34],"Herein,":[35],"we":[36],"evaluated":[37],"added":[39],"value":[40],"combining":[42],"two":[43],"blockers":[45],"(verapamil":[46],"and":[47,51,53,65,81,87,97,107,123,145,162,178,184,194,220],"resveratrol)":[48],"with":[49,105,155,173,196],"docetaxel":[50,88,108,221],"doxorubicin":[52,106,219],"possible":[55],"underlying":[56],"mechanism(s)":[57],"solid":[59,223],"cell":[61,164],"lines":[62],"(MCF\u20107,":[63],"HeLa":[64,161],"HepG2).":[66],"Verapamil":[67,103],"possessed":[68],"weaker":[69],"anti\u2010cancer":[70,216],"properties":[71],"than":[72],"resveratrol":[73,154,168,193,208],"(IC":[74],"50":[75,90,113,139],"92.1":[77],"to":[78,83,94,99,118,120,125,137,142,147,211],"107.6":[79],"\u03bcM":[80,96,122,144],"35.0":[82],"84\u03bcM,":[84],"respectively).":[85],"Doxorubicin":[86],"IC":[89,112,138],"'s":[91,114],"0.48":[93],"0.72":[95],"25.9":[98],"77.8":[100],"nM,":[101,127,149],"respectively.":[102,128,150],"combination":[104],"significantly":[109,190],"decreased":[110],"both":[116,134,156],"agents":[117,136,157],"0.034":[119],"0.12":[121,141],"2.5":[124],"6.0":[126],"Resveratrol":[129],"increased":[130],"potencies":[132],"chemotherapeutic":[135],"0.34":[143],"7.2":[146],"53.02":[148],"The":[151],"interaction":[152],"was":[158,189,209],"additive":[159],"Hep\u2010G2":[163],"lines.":[165],"Surprisingly,":[166],"only":[167],"but":[169],"not":[170],"verapamil":[171,195,212],"interfered":[172],"several":[179],"apoptotic":[180],"genes":[181],"BAX,":[182],"BcL2":[183],"p53.":[185],"efflux":[187],"activity":[188],"inhibited":[191],"subsequent":[197],"accumulation":[198],"substrate":[201],"within":[202],"compartment.":[205],"conclusion,":[207],"comparable":[210],"potentiating":[214],"effects":[217],"tumor.":[224]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2018,"cited_by_count":2}],"updated_date":"2026-10-13T10:08:12.033832","created_date":"2016-06-24T00:00:00"}